Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2026)
Whitehawk Therapeutics (WHWK) reported Amortizatization of Intangibles of $347000.0 for Q1 2026, up 1926.32% year-over-year from $17124.7 in Q1 2025, and down 58.24% on a QoQ basis from $831000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) has 4 years of Amortizatization of Intangibles data on file, last reported at $347000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 1926.32% year-over-year to $347000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 120.12% YoY) and the FY2025 annual result came in at $1.5 million, up 17.37% from the prior year.
- Amortizatization of Intangibles fell to $347000.0 in Q1 2026 per WHWK's latest filing, from $831000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.2 million in Q1 2023 and bottomed at -$19000.0 in Q1 2025.
- The 4-year median for Amortizatization of Intangibles is $422000.0 (2024), against an average of $485461.5.
- The widest annual swing landed in 2025, when Amortizatization of Intangibles sank 104.5%; it then jumped 1926.32% in 2026.
- Tracing WHWK's Amortizatization of Intangibles over 4 years: stood at $486000.0 in 2023, then tumbled by 62.35% to $183000.0 in 2024, then soared by 354.1% to $831000.0 in 2025, then plunged by 58.24% to $347000.0 in 2026.
- Per Business Quant, the three latest WHWK Amortizatization of Intangibles figures stand at $347000.0 (Q1 2026), $831000.0 (Q4 2025), and $717000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 347,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 347,000.00 |
| Mar 31, 2026 | 347,000.00 |
| Dec 31, 2025 | 831,000.00 |
| Dec 31, 2025 | 831,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 422,000.00 |
| Mar 31, 2024 | 422,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Sep 30, 2023 | 588,000.00 |
| Sep 30, 2023 | 588,000.00 |
| Jun 30, 2023 | 862,000.00 |
| Jun 30, 2023 | 862,000.00 |
| Mar 31, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.20 Mn |